ANESIVA, INC.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Create Email Alert

Anesiva is based out of South San Francisco. Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management. It has two products in clinical development, which include Zingo and 4975. Zingo is an anesthetic that has completed two Phase 3 trials in the pediatric population for the treatment of pain associated with venipuncture and cannulation; and 4975 is an anesthetic for the treatment of site-specific moderate to severe pain, and is in multiple Phase 2 and Phase 3 trials in post-surgical and musculoskeletal pain.Whalewisdom has at least 25 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-10-02. The notice included securities offered of Debt

Contact Info

anesiva, inc.
650 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO CA    94080

Business Phone: 6506249600
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2009-10-02 D/A BIOTECHNOLOGY Debt 2,200,000 2,200,000 0
2009-06-02 D BIOTECHNOLOGY Debt 2,000,000 2,000,000 0
2009-02-02 D BIOTECHNOLOGY Equity 7,000,000 3,000,000 4,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARNOLD L. ORONSKY subscription required
    DIRECTOR
DANIEL S. JANNEY subscription required
    DIRECTOR
JEAN-FREDERIC VIRET subscription required
    EXECUTIVE OFFICER
JOHN F. HAMILTON subscription required
    DIRECTOR
JOHN H. TRAN subscription required
    EXECUTIVE OFFICER
MICHAEL L. KRANDA subscription required
    EXECUTIVE OFFICER DIRECTOR
MICHAEL F. POWELL subscription required
    DIRECTOR
RODNEY A. FERGUSON subscription required
    DIRECTOR
WILLIAM C. HOUGHTON subscription required
    EXECUTIVE OFFICER

Elevate your investments